PMV Pharmaceuticals's total assets for Q3 2024 were $223.50M, a decrease of -5.91% from the previous quarter. PMVP total liabilities were $25.59M for the fiscal quarter, a 10.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.